Literature DB >> 10490624

Inhibition of src family kinases by a combinatorial action of 5'-AMP and small heat shock proteins, identified from the adult heart.

V S Kasi1, D Kuppuswamy.   

Abstract

Src family kinases are implicated in cellular proliferation and transformation. Terminally differentiated myocytes have lost the ability to proliferate, indicating the existence of a down-regulatory mechanism(s) for these mitogenic kinases. Here we show that feline cardiomyocyte lysate contains thermostable components that inhibit c-Src kinase in vitro. This inhibitory activity, present predominantly in heart tissue, involves two components acting combinatorially. After purification by sequential chromatography, one component was identified by mass and nuclear magnetic resonance spectroscopies as 5'-AMP, while the other was identified by peptide sequencing as a small heat shock protein (sHSP). 5'-AMP and to a lesser extent 5'-ADP inhibit c-Src when combined with either HSP-27 or HSP-32. Other HSPs, including alphaB-crystallin, HSP-70, and HSP-90, did not exhibit this effect. The inhibition, observed preferentially on Src family kinases and independent of the Src tyrosine phosphorylation state, occurs via a direct interaction of the c-Src catalytic domain with the inhibitory components. Our study indicates that sHSPs increase the affinity of 5'-AMP for the c-Src ATP binding site, thereby facilitating the inhibition. In vivo, elevation of ATP levels in the cardiomyocytes results in the tyrosine phosphorylation of cellular proteins including c-Src at the activatory site, and this effect is blocked when the 5'-AMP concentration is raised. Thus, this study reveals a novel role for sHSPs and 5'-AMP in the regulation of Src family kinases, presumably for the maintenance of the terminally differentiated state.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10490624      PMCID: PMC84682          DOI: 10.1128/MCB.19.10.6858

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  65 in total

1.  Crystal structure of Hck in complex with a Src family-selective tyrosine kinase inhibitor.

Authors:  T Schindler; F Sicheri; A Pico; A Gazit; A Levitzki; J Kuriyan
Journal:  Mol Cell       Date:  1999-05       Impact factor: 17.970

Review 2.  Heat shock proteins and cell proliferation.

Authors:  P M Pechan
Journal:  FEBS Lett       Date:  1991-03-11       Impact factor: 4.124

3.  Association between the PDGF receptor and members of the src family of tyrosine kinases.

Authors:  R M Kypta; Y Goldberg; E T Ulug; S A Courtneidge
Journal:  Cell       Date:  1990-08-10       Impact factor: 41.582

4.  Transcription of muscle-specific genes is repressed by reactivation of pp60v-src in postmitotic quail myotubes.

Authors:  G Falcone; S Alemà; F Tatò
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

5.  Down regulation by p60v-src of genes specifically expressed and developmentally regulated in postmitotic quail neuroretina cells.

Authors:  M Guermah; G Gillet; D Michel; D Laugier; G Brun; G Calothy
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

6.  A protein tyrosine kinase involved in regulation of pp60c-src function.

Authors:  M Okada; H Nakagawa
Journal:  J Biol Chem       Date:  1989-12-15       Impact factor: 5.157

7.  Muscle differentiation in cell culture. Effects of nucleoside inhibitors and Rous sarcoma virus.

Authors:  T G Easton; E Reich
Journal:  J Biol Chem       Date:  1972-10-25       Impact factor: 5.157

Review 8.  src expression in small-cell lung carcinoma and other neuroendocrine malignancies.

Authors:  S Påhlman; U Hammerling
Journal:  Am Rev Respir Dis       Date:  1990-12

9.  Purification and enzymatic characterization of pp60c-src from human platelets.

Authors:  D Feder; J M Bishop
Journal:  J Biol Chem       Date:  1990-05-15       Impact factor: 5.157

10.  Growth arrest of human B lymphocytes is accompanied by induction of the low molecular weight mammalian heat shock protein (Hsp28).

Authors:  N L Spector; W Samson; C Ryan; J Gribben; W Urba; W J Welch; L M Nadler
Journal:  J Immunol       Date:  1992-03-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.